Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
79.70
-0.53 (-0.66%)
Apr 23, 2025, 4:00 PM EDT - Market closed
PBH Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for PBH stock have an average target of 94, with a low estimate of 76 and a high estimate of 104. The average target predicts an increase of 17.94% from the current stock price of 79.70.
Analyst Consensus: Buy
* Price targets were last updated on Mar 21, 2025.
Analyst Ratings
The average analyst rating for PBH stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $96 → $97 | Hold | Maintains | $96 → $97 | +21.71% | Mar 21, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $87 → $93 | Buy | Maintains | $87 → $93 | +16.69% | Feb 13, 2025 |
| DA Davidson | DA Davidson | Strong Buy Maintains $95 → $104 | Strong Buy | Maintains | $95 → $104 | +30.49% | Feb 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $93 → $100 | Strong Buy | Maintains | $93 → $100 | +25.47% | Feb 7, 2025 |
| DA Davidson | DA Davidson | Strong Buy Maintains $95 | Strong Buy | Maintains | $95 | +19.20% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
1.14B
from 1.13B
Increased by 1.48%
Revenue Next Year
1.17B
from 1.14B
Increased by 2.28%
EPS This Year
4.55
from 4.17
Increased by 9.06%
EPS Next Year
4.82
from 4.55
Increased by 6.07%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.2B | 1.2B | 1.2B | |||
| Avg | 1.1B | 1.2B | 1.2B | |||
| Low | 1.1B | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.6% | 6.7% | 6.8% | |||
| Avg | 1.5% | 2.3% | 2.4% | |||
| Low | -1.6% | -1.4% | -1.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.75 | 5.08 | 5.35 | |||
| Avg | 4.55 | 4.82 | 5.08 | |||
| Low | 4.41 | 4.58 | 4.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 13.8% | 11.7% | 11.0% | |||
| Avg | 9.1% | 6.1% | 5.2% | |||
| Low | 5.8% | 0.6% | -1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.